Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH for Prevention of Early TIPS Dysfunction
NCT03171727Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2017
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of low molecular weight heparin calcium in transjugular intrahepatic portosystemic shunt dysfunction, sponsored by West China Hospital of Sichuan University. Primary endpoint: TIPS patency rate at 1 year. Status: unknown.
02
Drugs
low molecular weight heparin calcium
03
Conditions
transjugular intrahepatic portosystemic shunt dysfunction
Beyond the preview
Go deeper on NCT03171727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171727.